A QSAR study that compares the ability of bisdioxopiperazine analogs of the doxorubicin cardioprotective agent dexrazoxane (ICRF-187) to protect myocytes with DNA topoisomerase II inhibition
Author:
Funder
Canadian Institutes of Health Research
Canada Research Chairs Program
Canada Research Chair in Drug Development
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference33 articles.
1. TOP2B: the first thirty years;Austin;Int. J. Mol. Sci.,2018
2. Deferiprone protects against doxorubicin-induced myocyte cytotoxicity;Barnabé;Free Radic. Biol. Med.,2002
3. Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development;Capranico;Biochim. Biophys. Acta,1992
4. Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187;Classen;Proc. Natl. Acad. Sci. U. S. A.,2003
5. Pharmaceutical compositions;Creighton,1991
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nicotinamide Mononucleotide Supplementation Alleviates Doxorubicin-Induced Multi-Organ Fibrosis;International Journal of Molecular Sciences;2024-05-13
2. Structure-function analysis of the ATPase domain of African swine fever virus topoisomerase;mBio;2024-04-10
3. Benzimidazole based hybrids as privileged candidates for topoII inhibition: Design, synthesis and molecular modeling studies;Journal of Molecular Structure;2024-02
4. Multi-parameter cardiac magnetic resonance imaging detects anthracycline-induced cardiotoxicity in rabbits model;Heliyon;2023-11
5. A comprehensive structural analysis of the ATPase domain of human DNA topoisomerase II beta bound to AMPPNP, ADP, and the bisdioxopiperazine, ICRF193;Structure;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3